Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gore gets US green light for trial of stent graft for AV (arterio-venous grafts):

This article was originally published in Clinica

Executive Summary

WL Gore & Associates has received conditional approval from the US FDA to proceed with a clinical trial to compare use of its stent graft for arterio-venous grafts (AV) graft revisions against the use of percutaneous transluminal angioplasty (PTA) alone. The randomised, multicentre study, called AVIATOR, will test the efficacy and safety of the firm's Viabahn endoprosthesis with Propaten bioactive surface in AV graft revisions at the venous anastomosis in haemodialysis patients. The Flagstaff, Arizona firm's device represents the latest advance in its Viabahn product line.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT048883

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel